Bookmark

Add to MyYahoo RSS

Vertex News

News on Vertex (Ticker: VRTX) continually updated from thousands of sources around the net.

12 hrs ago | Business Wire

Vertex Receives European Approval for KALYDECOa (ivacaftor) in Eight Non-G551D Gating Mutations

Today's approval follows the positive opinion from the Committee for Medicinal Products for Human Use in June 2014.

Comment?

Related Topix: Biotech, Vertex Pharmaceuticals, Medicine, Healthcare Industry

13 hrs ago | AmericanBankingNews.com

Vertex Pharmaceuticals's Neutral Rating Reaffirmed at Zacks

's stock had its "neutral" rating restated by Zacks in a report released on Thursday.

Comment?

Related Topix: Biotech, Vertex Pharmaceuticals, Medicine, Healthcare Industry

Tue Jul 29, 2014

Hispanic Business

Vertex Reports Second Quarter 2014 Financial Results and Provides...

Vertex reported total second quarter 2014 revenues of , which adds to the company's cash balance.

Comment?

Related Topix: Biotech, Vertex Pharmaceuticals, Healthcare Industry

Sun Jul 27, 2014

The Olympian

How will we pay for a $300,000 drug?

Developed by Vertex Pharmaceuticals, it is the first drug that attacks not just the symptoms but the underlying cause of cystic fibrosis, a genetic lung disease that usually kills victims by the time they reach their 40s.

Comment?

Related Topix: Biotech, Vertex Pharmaceuticals, Medicine, Healthcare Industry, Cystic Fibrosis, Health, Fibrosis, Genetics, Healthcare Law, Law

Wed Jul 23, 2014

Chemical & Engineering News

Cystic Fibrosis Drug Combination May Be Counteracting Itself

Combination therapies are a promising strategy for correcting the most common gene mutation responsible for cystic fibrosis.

Comment?

Related Topix: Medicine, Cystic Fibrosis, Health, Fibrosis, Biotech, Vertex Pharmaceuticals, Healthcare Industry, University of North Carolina Chapel Hill

Boston.com

Tests suggest limitations to Vertex's cystic fibrosis treatment

Investors and patients were exuberant last month when Vertex Pharmaceuticals released results from clinical trials showing that cystic fibrosis patients' lung function improved on an experimental two-drug regimen.

Comment?

Related Topix: Medicine, Cystic Fibrosis, Health, Fibrosis, Biotech, Vertex Pharmaceuticals, Healthcare Industry, Healthcare Law, Food and Drug Administration, Law

Customer Interaction Solutions

Investor Alert: Class Action Lawsuit Against Vertex Pharmaceuticals...

Law Offices of Howard G. Smith announces that a class action lawsuit has been filed in the United States District Court for the District of Massachusetts on behalf of all purchasers of the common stock of Pharmaceuticals Incorporated between May 7, 2012 and May 29, 2012, inclusive .

Comment?

Related Topix: Biotech, Vertex Pharmaceuticals, Medicine, Healthcare Industry

Mon Jul 14, 2014

The Motley Fool

Up 33%: Is Vertex Pharmaceuticals Stock Overpriced?

Those positive data were a big reason why the stock is up 32% year-to-date. These trials-nicknamed "TRAFFIC" and "TRANSPORT" enrolled a total of 1,100 patients across 200 research centers.

Comment?

Related Topix: Biotech, Vertex Pharmaceuticals, Medicine, Healthcare Industry, Healthcare Law, Law

Freshnews

Vertex to Announce Second Quarter 2014 Financial Results on July 29

Vertex Pharmaceuticals Incorporated will report its second quarter 2014 financial results on Tuesday, July 29, 2014 after the financial markets close.

Comment?

Related Topix: Biotech, Vertex Pharmaceuticals, Medicine, Healthcare Industry

Sys-Con Media

Atlantis Computing(R) Announces Record 1H Bookings, Appoints New CEO

Atlantis Computing , the leading provider of Software-Defined Storage, today announced it has delivered record-breaking 1H bookings and its Board of Directors has appointed Jason Donahue as Chief Executive Officer, President, and member of the Board of Directors.

Comment?

Related Topix: Startups, Acronis, ClearApp, Phase Forward, Project Insight, Software

Fri Jul 11, 2014

The Motley Fool

1 Drug More Important to Gilead Than Sovaldi

Sales of the drug totaled more than $2.2 billion in its first quarter on the market, making it the fastest drug to ever reach billion-dollar blockbuster status, and one of the planet's top-selling drugs.

Comment?

Related Topix: Biotech, Vertex Pharmaceuticals, Medicine, Healthcare Industry

Business Journal

On the Move: Personnel moves in local life sciences industry

Here's a summary of recent personnel changes and board appointments announced at Massachusetts biotech, pharmaceutical and medical device companies: Arch Therapeutics in Wellesley, developer of the AC5 Surgical Hemostatic Device, a novel product aimed at controlling bleeding and fluid loss, has appointed Richard Davis as CFO and treasurer.

Comment?

Related Topix: Medicine, NMT Medical, Medical Equipment, Healthcare Industry, Watertown, MA, Biotech, Vertex Pharmaceuticals

USA Today

6 stocks going bananas this summer

It's been a "Planet of Boring Stocks" this summer so far for most investors, with the market just about dead flat.

Comment?

Related Topix: Financial Markets, Retail, PETsMART, Pets, Biotech, Vertex Pharmaceuticals, Medicine, Healthcare Industry, Iron Mountain

Thu Jul 10, 2014

Freshnews

Vertex Announces Retirement of Peter Mueller, Ph.D.

Vertex Pharmaceuticals Incorporated today announced that Peter Mueller, Ph.D., Executive Vice President of Global Research and Development and Chief Scientific Officer, will retire after more than 10 years with the company.

Comment?

Related Topix: Biotech, Vertex Pharmaceuticals, Medicine, Healthcare Industry

Wed Jul 09, 2014

AmericanBankingNews.com

Vertex Pharmaceuticals Stock Rating Upgraded by TheStreet

The analysts wrote, "Vertex Pharmaceuticals has been upgraded by TheStreet Ratings from sell to hold.

Comment?

Related Topix: Biotech, Vertex Pharmaceuticals, Medicine, Healthcare Industry

Mon Jul 07, 2014

AmericanBankingNews.com

Vertex Pharmaceuticals Lowered to Market Perform at Oppenheimer

In other Vertex Pharmaceuticals news, Director Elaine Ullian sold 5,000 shares of Vertex Pharmaceuticals stock on the open market in a transaction that occurred on Tuesday, July 1st.

Comment?

Related Topix: Biotech, Vertex Pharmaceuticals, Medicine, Healthcare Industry

Fri Jul 04, 2014

Philly.com

Economy creates 288,000 jobs in June; Dow breaks 17,000 on news

The economy created a whopping 288,000 jobs in June, and in celebration, the Dow Jones industrial average surpassed 17,000 for the first time.

Comment?

Related Topix: New Jersey, Consulting, Challenger Gray and Christmas

Thu Jul 03, 2014

Freshnews

The Zacks Analyst Blog Highlights: Vertex Pharmaceuticals, MannKind,...

Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets.

Comment?

Related Topix: Biotech, Vertex Pharmaceuticals, MannKind, Medicine, Healthcare Industry, Financial Markets, Auxilium Pharmaceuticals, QLT

•••
•••
•••
•••
•••

Seattle Jobs

•••
•••
•••
•••